Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow (original) (raw)

Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies

Nature Reviews Cancer, 2009

Inhibitors of nitric oxide synthase selectively reduce flow in tumour-associated neovasculature

Ian Hart

British Journal of Pharmacology, 1992

The Influence of Nitric Oxide on Tumour Vascular Tone

Acta Oncologica, 1995

Perivascular nitric oxide gradients normalize tumor vasculature

William Sessa

Nature Medicine, 2008

Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1

Proceedings of the National Academy of Sciences, 2005

Inhibition of Nitric Oxide Synthase Induces a Selective Reduction in Tumor Blood Flow That Is Reversible with L-Arginine

Cancer Research, 1997

Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma

Robert Meyer

British journal of cancer, 1995

The Biphasic Nature of Nitric Oxide Responses in Tumor Biology

Antioxidants & Redox Signaling, 2006

Nitric oxide in tumour biology and cancer therapy. Part 1: Physiological aspects

Clinical Oncology, 1997

Modification of tumor blood flow: Current status and future directions

Seminars in Radiation Oncology, 1998

Disparate responses of tumour vessels to angiotensin II: tumour volume-dependent effects on perfusion and oxygenation

Peter Vaupel

British Journal of Cancer, 2000

Regulation of tumor angiogenesis by thrombospondin-1

Jack Lawler

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2006

Tumor Vascular Changes Mediated by Inhibition of Oncogenic Signaling

L. Balathasan, Ruth Muschel

Cancer Research, 2009

Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner

Lisa Ridnour

Proceedings of the National Academy of Sciences, 2005

Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions

Sandra T van Tiel

British journal of cancer, 2000

Molecular Mechanisms of Tumor Angiogenesis

Sergey Kiselev

Genes & Cancer, 2011

In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects

Philippe Clézardin

Genes & Development, 2001

Molecular Regulation of Tumor Angiogenesis and Perfusion via Redox Signaling

Chemical Reviews, 2009

Nitric oxide synthase is expressed in experimental malignant glioma and influences tumour blood flow

Ian Whittle

Acta Neurochirurgica, 1996

Influence of vasoactive drugs on local tumor blood flow

Jan Mattsson

European Journal of Cancer and Clinical Oncology, 1982

Thrombospondins and tumor angiogenesis

Jean-jacques Feige

Trends in Molecular …, 2001

Overexpression of Thrombospondin-1 Reduces Growth and Vascular Index but not Perfusion in Glioblastoma1

Bjørn Quistorff

Cancer Research, 2002

Effects of nitric oxide modulation on tumour blood flow and microvascular permeability in C6 glioma

Count Grog

NeuroReport, 1998

Reactivity of tumor-draining lymph nodes and the nitric oxide pathway

Ana Eijan

International journal of oncology, 2002

Alternative Vascularization Mechanisms in Cancer

József Tóvári

The American Journal of Pathology, 2007

Nitric oxide and anti-cancer therapy

sagar singh

Cancer Treatment Reviews, 1995

Nitric oxide delivery to cancer: Why and how?

Bénédicte Jordan

European Journal of Cancer, 2009

Thrombospondin-1 Associated with Tumor Microenvironment Contributes to Low-Dose Cyclophosphamide-Mediated Endothelial Cell Apoptosis and Tumor Growth Suppression

Jack Lawler

Cancer Research, 2004

Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation

Blood, 2007

Overexpression of thrombospondin-1 reduces growth and vascular index but not perfusion in glioblastoma

Erwin G . Van Meir

Cancer research, 2002

p73 overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis

C. Ghilardi

Oncogene, 2001

THE ANTIANGIOGENIC EFFECTS OF THROMBOSPONDIN1 AND -2 IN TUMORS

Dorina Munteanu

2000

“Vasocrine” Formation of Tumor Cell-lined Vascular Spaces Implications for Rational Design of Antiangiogenic Therapies

Melinda G Hollingshead

Cancer Research

Nitric oxide—A novel therapeutic for cancer

Jonathan Coulter, Ernst Wagner, David Hirst

Nitric Oxide, 2008